Pharmacovigilance Outsourcing Market Report 2026

Pharmacovigilance Outsourcing Market Overview

• Pharmacovigilance Outsourcing market size has reached to $7.24 billion in 2025 • Expected to grow to $16.09 billion in 2030 at a compound annual growth rate (CAGR) of 17.2% • Growth Driver: Clinical Trials Propel Growth Of The Pharmacovigilance Outsourcing Market • Market Trend: Advanced Cloud-Based Data Lake Platform Enhances Pharmacovigilance And Safety Data Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pharmacovigilance Outsourcing Market?

Pharmacovigilance outsourcing refers to the practice of hiring external service providers to manage and conduct pharmacovigilance activities on behalf of pharmaceutical companies. These activities include detecting, assessing, understanding, and preventing adverse effects or any other drug-related problems. The main types of pharmacovigilance outsourcing are adverse drug reaction capture (ADR), case processing, reporting and submission, report publishing, quality check, risk management, knowledge management, and enabling architecture. Adverse drug reaction capture (ADR) is the process of identifying, documenting, and analyzing any harmful or unintended reactions to a medication, used to ensure drug safety and improve patient care. Pharmacovigilance outsourcing services are provided by organizations such as contract research organizations and business processing outsourcing companies. The end users of these outsourced services include the pharmaceutical industry, research organizations, and others.

What Is The Pharmacovigilance Outsourcing Market Growth Forecast?

The pharmacovigilance outsourcing market size is expected to see rapid growth in the next few years. It will grow to $16.09 billion in 2030 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to integration of ai and data analytics in pv processes, increasing outsourcing to cro and bpo providers, adoption of cloud-based pharmacovigilance platforms, expansion of global safety reporting requirements, growing investment in it infrastructure and technology support. Major trends in the forecast period include increasing adoption of outsourced pharmacovigilance services by pharma companies, rising regulatory compliance requirements and reporting standards, growth in automation of adr capture and case processing, expansion of knowledge management and data integration solutions, enhanced focus on risk management and quality assurance services.

Global Pharmacovigilance Outsourcing Market Segmentation

1) By Type: Adverse Drug Reaction Capture (ADR), Case Processing, Reporting And Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, Enabling Architecture 2) By Service Provider: Contract Research Organization, Business Processing Outsourcing 3) By End User: Pharmaceutical Industry, Research Organization, Other End Users Subsegments: 1) By Adverse Drug Reaction Capture (ADR): Automated ADR Reporting Tools, Manual ADR Reporting Solutions, ADR Data Mining Software 2) By Case Processing: Case Intake and Triage Services, Medical Review and Evaluation Services, Data Entry and Management Services 3) By Reporting And Submission: Regulatory Reporting Services, Submission to Health Authorities, Compliance Tracking Services 4) By Report Publishing: Clinical Study Report Publishing, Safety Update Report Publishing, Final Study Report Publishing 5) By Quality Check: Quality Assurance Services, Audit and Inspection Services, Compliance Monitoring Services 6) By Risk Management: Risk Assessment Services, Risk Minimization Strategies, Benefit-Risk Evaluation Services 7) By Knowledge Management: Data Management Solutions, Pharmacovigilance Database Management, Knowledge Sharing Platforms 8) By Enabling Architecture: IT Infrastructure Solutions, Data Integration Services, Technology Platform Support

What Is The Driver Of The Pharmacovigilance Outsourcing Market?

The rising number of clinical trials is expected to propel the growth of the pharmacovigilance outsourcing market going forward. Clinical trials are research studies conducted to evaluate the safety, efficacy, and potential side effects of new treatments, drugs, or medical devices. Clinical trials are rising due to several reasons, including the growing focus on precision medicine, the rising incidence of chronic diseases, regulatory support, and the globalization of research. Pharmacovigilance outsourcing in clinical trials enhances drug safety monitoring by leveraging specialized expertise and resources to ensure compliance with regulatory requirements and improve efficiency. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade association, the number of industry clinical trials initiated in the UK increased to 426 in 2023, from 411 in 2022. Therefore, the rising number of clinical trials is driving the growth of the pharmacovigilance outsourcing industry.

Key Players In The Global Pharmacovigilance Outsourcing Market

Major companies operating in the pharmacovigilance outsourcing market are ACCENTURE PLC, International Business Machines Corporation (IBM), Tata Consultancy Services, Capgemini SE, Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., Wipro Limited, ICON PLC, Syneos Health, Genpact limited, Parexel International Corp, Veeva Systems Inc., Medpace Holdings Inc., ProPharma Group, Pharmalex GmbH, PrimeVigilance Ltd., Veristat LLC, United BioSource LLC, Lambda Therapeutic Research, ArisGlobal, Biomapas

Global Pharmacovigilance Outsourcing Market Trends and Insights

Major companies operating in the pharmacovigilance outsourcing market are focusing on developing innovative solutions, such as a cloud-based data lake platform, to optimize pharmacovigilance case processing and safety data management processes for enhancing clinical research registries and ensuring compliance with regulatory requirements. A cloud-based data lake platform is a centralized repository that allows you to store and manage large amounts of raw data in its native format until it’s needed. For instance, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and laboratory equipment company, launched CorEvidence, designed to enhance clinical research registries. It is designed to streamline pharmacovigilance case processing by handling multiple data sources and optimizing the coding, classification, and reporting of adverse events. Its significance lies in providing scalable, compliant, and auditable safety management, enhancing CorEvitas clinical research registries, and supporting long-term post-authorization safety studies across multiple therapeutic areas.

What Are Latest Mergers And Acquisitions In The Pharmacovigilance Outsourcing Market?

In November 2023, Permira Advisers LLP, a UK-based investment firm, acquired Ergomed PLC for $0.904 billion. This acquisition aims to support Ergomed's next phase of growth by leveraging Permira's expertise, capital, and global network to expand Ergomed's commercial, technological, and geographic capabilities, as well as to facilitate strategic acquisitions in the contract research organization (CRO) and pharmacovigilance (PV) sectors. Ergomed PLC is a UK-based company providing drug development services, including pharmacovigilance.

Regional Insights

North America was the largest region in the pharmacovigilance outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmacovigilance Outsourcing Market?

The pharmacovigilance outsourcing market includes revenues earned by entities by providing services such as pharmacovigilance database management, assessment services, medical information call center services, regulatory consulting and strategy services, pharmacovigilance compliance and auditing, and aggregate reporting and benefit-risk evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmacovigilance Outsourcing Market Report 2026?

The pharmacovigilance outsourcing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacovigilance outsourcing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.